X

WHY BLOOM BURTON & CO?
SERVICES
TRANSACTIONS
TEAM
EVENTS
News & Insights
CAREERS
CONTACT

•

M

E

N

U

•

March 31, 2016

Bloom Burton’s analyst David Martin speaks to BNN about Concordia's latest earnings

Click on the image to view the full video.

RELATED NEWS

APOTEX HEALTH CORP. ANNOUNCES CLOSING OF UPSIZED INITIAL PUBLIC OFFERING AND EXERCISE OF OVER-ALLOTMENT OPTION IN FULL PharmaEssentia Expands North American Commercial Footprint with Acquisition of Canadian Partner FORUS Therapeutics Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million Medicenna Announces Closing of Public Offering of Units Raising CDN$4.44 Million to Support Lead Programs Richards Group Inc. Announces Acquisition of the CPG Assets of PharmaSystems Inc. Three Finalists Announced for the 2026 Bloom Burton Award Crescita Announces Definitive Agreement to Be Acquired by ClinActiv Holdings in an All-Cash Transaction at a Significant Premium Australian-Listed @PYC Therapeutics (ASX:PYC) Raises A$600 Million from Leading Healthcare Specialist Investors, Institutional Investors and Existing Investors Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option Registration is now open for the 2026 Bloom Burton & Co. Healthcare Investor Conference!

2026 BLOOM BURTON & CO | WEBSITE BY PIXELCARVE | MEMBER CIRO | MEMBER CIPF | PRIVACY POLICY | COMPLAINT | BEST EXECUTION POLICY | ACCESSIBILITY POLICY | BUSINESS CONTINUITY PLAN | LEGAL DISCLAIMER | CONFLICTS OF INTEREST